Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery

NCT02437825 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Fistula; Salivary Duct or Gland

Interventions

DRUG: octreotide
OTHER: placebo

Sponsor

Hadassah Medical Organization